Natural Compounds and CYP3A4 — HER2CLIMB Considerations

Many people use supplements alongside cancer treatment. Some of these compounds may affect liver enzymes and transporters, especially CYP3A4, which matters for drugs such as tucatinib.

Why CYP3A4 matters here

Within the HER2CLIMB regimen, the main CYP3A4 concern centres on tucatinib.

• Tucatinib has meaningful CYP3A4 interaction relevance

• Capecitabine is not primarily cleared through CYP3A4

• Trastuzumab is not handled through CYP3A4 metabolism

That means supplement-related CYP3A4 questions in this regimen are usually about whether they may alter tucatinib exposure.

How to use this page

Use this page as a practical discussion guide.

It does not prove that a given supplement will definitely raise or lower tucatinib levels in a real patient. In most cases, the evidence is still preclinical, mixed, or formulation-dependent.

Curcumin

What it is

Curcumin is the main yellow polyphenol in turmeric. It is commonly used for anti-inflammatory and antioxidant support.

How it may affect CYP3A4

• preclinical studies suggest curcumin can inhibit CYP3A4

• some metabolite data suggest possible activation in some settings

• the overall effect may depend on dose, formulation, and metabolism

Evidence in brief

• cell-based assays have shown strong CYP3A4 inhibition at micromolar concentrations

• some studies suggest curcumin metabolites can increase CYP3A4 activity

• human oncology interaction data remain limited

Points to discuss with the care team

• whether the person is using turmeric or a high-dose curcumin product

• the exact formulation and dose

• whether there are unexpected tucatinib side effects or tolerability changes

See also: Curcumin Pharmacokinetics & Metabolism

EGCG

What it is

EGCG is the main catechin in green tea and in many green-tea extracts.

How it may affect CYP3A4

• EGCG can inhibit CYP3A4 in vitro

• the effect appears concentration-dependent

• repeated human dosing studies suggest the real-world effect may be modest or variable

Evidence in brief

• human liver microsome studies support CYP3A4 inhibition

• animal data suggest pharmacokinetic interactions with some drugs

• repeated human catechin dosing has often shown limited CYP change overall

Points to discuss with the care team

• daily green tea intake

• use of high-dose EGCG extracts

• whether there are changes in treatment tolerance that might reflect altered drug handling

See also: EGCG Pharmacokinetics & Metabolism

Quercetin

What it is

Quercetin is a flavonoid found in many foods and in standalone antioxidant supplements.

How it may affect CYP3A4

• quercetin inhibits CYP3A4 in a concentration-dependent way

• it may also inhibit P-glycoprotein

• combined CYP3A4 and transporter inhibition could increase oral drug exposure

Evidence in brief

• in vitro data support CYP3A4 inhibition

• animal work suggests increased exposure to some orally administered drugs

• metabolite activity appears weaker than parent-compound activity

Points to discuss with the care team

• whether quercetin is being used as a single supplement or inside a blend

• whether P-gp interaction relevance may matter as much as CYP3A4

• whether side effects could reflect increased tucatinib exposure

Resveratrol

What it is

Resveratrol is a stilbene polyphenol found in grapes, berries, and some supplements.

How it may affect CYP3A4

• resveratrol can inhibit CYP3A4 in vitro

• it has also been described as a mechanism-based inactivator

• it may suppress inducible CYP3A4 expression through PXR-related pathways

Evidence in brief

• intestinal and liver models support CYP3A4 inhibition

• some clinical data suggest higher exposure to drugs metabolised by CYP3A4

• the real effect depends on dose, product, and co-medications

Points to discuss with the care team

• whether resveratrol is being used directly or indirectly via related products

• whether there is concern about higher tucatinib exposure

• whether liver function and side effects need closer review

HER2-positive breast-cancer caution

• this is a separate caution from the CYP3A4 question

• in HER2-positive, ERα-positive breast cancer, there is a specific Δ16HER2 / resveratrol concern

• in a Δ16HER2 transgenic breast-cancer model, resveratrol accelerated tumour development rather than suppressing it

• because polydatin is metabolised toward resveratrol, that caution should also be kept in mind when discussing polydatin

• this signal is important, but it has not been confirmed in human oncology trials

See also: Should HER2+/ERα+ Patients Avoid Resveratrol or Polydatin? and HER2+ Cancers

Milk thistle / silymarin

What it is

Milk thistle is a herbal extract used mainly for liver support. Silymarin is its main active flavonolignan complex.

How it may affect CYP3A4

• preclinical work suggests CYP3A4 inhibition is possible

• some studies show strong suppression in cell systems

• human findings are mixed and may depend on dose and formulation

Evidence in brief

• liver-cell and microsomal studies support inhibition potential

• some patient studies have shown little measurable CYP3A4 effect

• real-world impact may vary with the extract used

Points to discuss with the care team

• the exact milk thistle product and standardisation

• whether it is being used daily during tucatinib treatment

• whether liver tests, tolerability, or exposure concerns justify review

See also: Pharmacokinetics, Bioavailability & Dosing

Bottom line

The safest working assumption is that several commonly used natural compounds may have some CYP3A4 relevance, but the size and direction of the effect in a real patient are often uncertain.

That is why the practical question is usually not just "does this supplement affect CYP3A4?" but "does it affect it enough to matter for this treatment, at this dose, in this person?"

Related pages

• Drug Interaction Evidence and CYP Enzymes

• HER2CLIMB Guide

• HER2CLIMB Resistance Mechanisms

• Tucatinib Clearance, Genetics, and Enzyme Inducers

• Liquid Biopsy for HER2-Positive Resistance

References

Curcumin

Oral intake of curcumin markedly activated CYP3A4
https://www.nature.com/articles/srep06587

Curcuminoids inhibit multiple human cytochromes P450
https://pubmed.ncbi.nlm.nih.gov/18480186/

Possible inhibitory mechanism of Curcuma drugs on CYP3A4
https://www.sciencedirect.com/science/article/abs/pii/S0378517307000026

Curdione plays an important role in the inhibitory effect of Curcuma drugs
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137788/

Inhibition of human recombinant cytochrome P450s by Curcuma constituents
https://www.sciencedirect.com/science/article/abs/pii/S0300483X07001515

EGCG

Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450
https://pubmed.ncbi.nlm.nih.gov/27518169/

Inhibition by green tea catechins of metabolic activation
https://www.sciencedirect.com/science/article/abs/pii/S0027510701002044

Effects of Repeated Green Tea Catechin Administration on Human CYP Activity
https://aacrjournals.org/cebp/article/15/12/2473/264497/Effects-of-Repeated-Green-Tea-Catechin

An Appraisal of Drug-Drug Interactions with Green Tea
https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0043-100934.pdf

The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Drugs
https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.907986/full

Quercetin

Role of CYP3A4 and P-gp inhibition by quercetin
https://pubmed.ncbi.nlm.nih.gov/21544726/

Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronide Metabolites
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468908/

Quercetin pretreatment increases the bioavailability of doxorubicin
https://www.sciencedirect.com/science/article/abs/pii/S0006295208000622

Interactions between CYP3A4 and Dietary Polyphenols
https://onlinelibrary.wiley.com/doi/10.1155/2015/854015

Quercetin inhibits arachidonic acid metabolism by CYP enzymes
https://pubmed.ncbi.nlm.nih.gov/37710176/

Resveratrol

Inhibition of cytochrome P450 3A by acetoxylated resveratrol derivatives
https://www.nature.com/articles/srep31557

Resveratrol suppresses the inducible expression of CYP3A4
https://pubmed.ncbi.nlm.nih.gov/25341566/

Resveratrol is a mechanism-based inactivator of CYP3A4
https://pubmed.ncbi.nlm.nih.gov/11125847/

Interactions of resveratrol and its metabolites with human CYP enzymes
https://www.sciencedirect.com/science/article/pii/S075333222200525X

Trans-resveratrol, but not other natural stilbenes, inhibits CYP3A4
https://www.sciencedirect.com/science/article/abs/pii/S037842741831988X

Milk thistle/silymarin

Milk Thistle, a Herbal Supplement, Decreases CYP3A4 Activity
https://www.sciencedirect.com/science/article/abs/pii/S0090955624150714

Milk thistle decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase
https://pubmed.ncbi.nlm.nih.gov/11038151/

The Effects of Milk Thistle on Human Cytochrome P450 Activity
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164972/

Would you like to ask Abbey about the information shared on this page? Would you like to contribute your experience, research or ideas to this page? Perhaps you want to point out something that needs changing?

Feedback Form